Revance Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $474k | 54k | 8.80 |
| 2023-09-30 | $578k | 50k | 11.47 |
| 2023-06-30 | $1.2M | 46k | 25.32 |
| 2023-03-31 | $1.4M | 43k | 32.22 |
| 2022-12-31 | $801k | 43k | 18.47 |
| 2022-03-31 | $739k | 38k | 19.50 |
| 2021-12-31 | $528k | 32k | 16.32 |
| 2021-09-30 | $689k | 25k | 27.84 |
| 2021-06-30 | $728k | 25k | 29.66 |
| 2021-03-31 | $622k | 22k | 27.97 |
| 2020-12-31 | $826k | 29k | 28.34 |
| 2020-09-30 | $561k | 22k | 25.15 |
| 2020-06-30 | $481k | 20k | 24.42 |
| 2020-03-31 | $283k | 19k | 14.79 |
| 2019-12-31 | $264k | 16k | 16.25 |
| 2019-09-30 | $359k | 28k | 13.01 |
| 2019-06-30 | $355k | 27k | 12.98 |
| 2019-03-31 | $429k | 27k | 15.77 |
| 2018-12-31 | $279k | 14k | 20.15 |